1887

Journal of General Virology header logo

Volume 97, Issue 9

Identification of human cytomegalovirus in tumour tissues of colorectal cancer and its association with the outcome of non-elderly patients Free

Abstract

Increasing evidence suggests that human cytomegalovirus (HCMV) plays an oncomodulatory role in human cancers. In colorectal cancer (CRC), presence of HCMV in tumours has been associated with a poor outcome in elderly patients. This study aimed to investigate the association between HCMV and the outcome of non-elderly patients with CRC. In tumour samples, HCMV DNA was detected by PCR. Viral transcript and protein were detected by hybridization (ISH) and immunohistochemical staining (IHC), respectively. Clinical, pathological and survival data were compared between patients with HCMV-positive and -negative tumours. Quantitative reverse transcription PCR (qRT-PCR) was used to analyse the expression levels of cellular signals related to CRC progression and metastasis. Among 89 CRC non-elderly patients aged <65 years, HCMV was detected in 31 (34.8 %) tumour samples by PCR. By ISH and IHC, viral transcript and protein specifically localized to the cytoplasm of neoplastic mucosal epithelium. Outcome analysis revealed a more favourable disease-free survival (DFS) rate in patients with HCMV-positive tumours (<0.01), specifically in patients with stage III disease. In a multivariate Cox proportional-hazard model, tumoural presence of HCMV independently predicted a higher DFS rate (hazard ratio 0.22; 95 % confidence interval 0.075–0.66, <0.01). By qRT-PCR, the tumoural levels of interleukin-1 were relatively lower in samples positive for HCMV. The results suggest that HCMV may influence the outcome of CRC in an age-dependent manner and possibly has a dual oncomodulatory effect. How the virus interacts with the tumour microenvironment should be further studied.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): colorectal cancer , Human cytomegalovirus , non-elderly , oncomodulation and survival
© 2016 The Authors
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000558
2016-09-01
2024-04-27
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/9/2411.html?itemId=/content/journal/jgv/10.1099/jgv.0.000558&mimeType=html&fmt=ahah

References

  1. Akintola-Ogunremi O., Luo Q., He T. C., Wang H. L. 2005; Is cytomegalovirus associated with human colorectal tumorigenesis?. Am J Clin Pathol 123:244–249 [View Article][PubMed]
     [Google Scholar]
  2. Boguszaková L., Hirsch I., Brichácek B., Faltýn J., Fric P., Dvoráková H., Vonka V. 1988; Absence of cytomegalovirus, Epstein-Barr virus, and papillomavirus DNA from adenoma and adenocarcinoma of the colon. Acta Virol 32:303–308[PubMed]
     [Google Scholar]
  3. Brichácek B., Hirsch I., Závadová H., Procházka M., Faltýn J., Vonka V. 1980; Absence of cytomegalovirus DNA from adenocarcinoma of the colon. Intervirology 14:223–227[PubMed] [CrossRef]
     [Google Scholar]
  4. Cai Z. Z., Xu J. G., Zhou Y. H., Zheng J. H., Lin K. Z., Zheng S. Z., Ye M. S., He Y., Liu C. B. et al. 2016; Human cytomegalovirus-encoded US28 may act as a tumor promoter in colorectal cancer. World J Gastroenterol 22:2789–2798 [View Article][PubMed]
     [Google Scholar]
  5. Chen H. P., Jiang J. K., Chen C. Y., Chou T. Y., Chen Y. C., Chang Y. T., Lin S. F., Chan C. H., Yang C. Y. et al. 2012; Human cytomegalovirus preferentially infects the neoplastic epithelium of colorectal cancer: a quantitative and histological analysis. J Clin Virol 54:240–244 [View Article][PubMed]
     [Google Scholar]
  6. Chen H. P., Jiang J. K., Lai P. Y., Chen C. Y., Chou T. Y., Chen Y. C., Chan C. H., Lin S. F., Yang C. Y. et al. 2014; Tumoral presence of human cytomegalovirus is associated with shorter disease-free survival in elderly patients with colorectal cancer and higher levels of intratumoral interleukin-17. Clin Microbiol Infect 20:664–671 [View Article][PubMed]
     [Google Scholar]
  7. Chen H. P., Jiang J. K., Lai P. Y., Teo W. H., Yang C. Y., Chou T. Y., Lin C. H., Chan Y. J. 2016; Serological and viraemic status of human cytomegalovirus infection in patients with colorectal cancer is not correlated with viral replication and transcription in tumours. J Gen Virol 97:152–159 [View Article][PubMed]
     [Google Scholar]
  8. Cobbs C. S., Harkins L., Samanta M., Gillespie G. Y., Bharara S., King P. H., Nabors L. B., Cobbs C. G., Britt W. J. 2002; Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62:3347–3350[PubMed]
     [Google Scholar]
  9. Cobbs C., Khan S., Matlaf L., McAllister S., Zider A., Yount G., Rahlin K., Harkins L., Bezrookove V. et al. 2014; HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activation. Oncotarget 5:1091–1100 [View Article][PubMed]
     [Google Scholar]
  10. Couzi L., Levaillant Y., Jamai A., Pitard V., Lassalle R., Martin K., Garrigue I., Hawchar O., Siberchicot F. et al. 2010; Cytomegalovirus-induced γδ T cells associated with reduced cancer risk after kidney transplantation. J Am Soc Nephrol 21:181–188 [View Article][PubMed]
     [Google Scholar]
  11. Dimberg J., Hong T. T., Skarstedt M., Löfgren S., Zar N., Matussek A. 2013; Detection of cytomegalovirus DNA in colorectal tissue from Swedish and Vietnamese patients with colorectal cancer. Anticancer Res 33:4947–4950[PubMed]
     [Google Scholar]
  12. Furman D., Jojic V., Sharma S., Shen-Orr S. S., Angel C. J., Onengut-Gumuscu S., Kidd B. A., Maecker H. T., Concannon P. et al. 2015; Cytomegalovirus infection enhances the immune response to influenza. Sci Transl Med 7:281ra43 [View Article]
     [Google Scholar]
  13. Giraldo G., Beth E., Huang E. S. 1980; Kaposi's sarcoma and its relationship to cytomegalovirus (CMNV). III. CMV DNA and CMV early antigens in Kaposi's sarcoma. Int J Cancer 26:23–29 [View Article][PubMed]
     [Google Scholar]
  14. Greenhough A., Smartt H. J. M., Moore A. E., Roberts H. R., Williams A. C., Paraskeva C., Kaidi A. 2009; The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 30:377–386 [View Article]
     [Google Scholar]
  15. Haggar F. A., Boushey R. P. 2009; Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 22:191–197 [View Article][PubMed]
     [Google Scholar]
  16. Huang G., Yan Q., Wang Z., Chen X., Zhang X., Guo Y., Li J. J. 2002; Human cytomegalovirus in neoplastic cells of Epstein-Barr virus negative Hodgkin's disease. Int J Oncol 21:31–36 [View Article][PubMed]
     [Google Scholar]
  17. Lewis A. M., Varghese S., Xu H., Alexander H. R. 2006; Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J Transl Med 4:48 [CrossRef]
     [Google Scholar]
  18. Li X., Qian D., Ju F., Wang B. 2015; Upregulation of Toll-like receptor 2 expression in colorectal cancer infected by human cytomegalovirus. Oncol Lett 9:365–370 [View Article][PubMed]
     [Google Scholar]
  19. McSharry B. P., Tomasec P., Neale M. L., Wilkinson G. W. 2003; The most abundantly transcribed human cytomegalovirus gene (β 2.7) is non-essential for growth in vitro . J Gen Virol 84:2511–2516 [View Article][PubMed]
     [Google Scholar]
  20. Michaelis M., Doerr H. W., Cinatl J. 2009; The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia 11:1–9 [View Article][PubMed]
     [Google Scholar]
  21. Naito Y., Saito K., Shiiba K., Ohuchi A., Saigenji K., Nagura H., Ohtani H. 1998; CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58:3491–3494[PubMed]
     [Google Scholar]
  22. Pacsa A. S., Kummerländer L., Pejtsik B., Pali K. 1975; Herpesvirus antibodies and antigens in patients with cervical anaplasia and in controls. J Natl Cancer Inst 55:775–781[PubMed]
     [Google Scholar]
  23. Pawelec G., Derhovanessian E., Larbi A. 2010; Immunosenescence and cancer. Crit Rev Oncol Hematol 75:165–172 [View Article][PubMed]
     [Google Scholar]
  24. Peddareddigari V. G., Wang D., Dubois R. N. 2010; The tumour microenvironment in colorectal carcinogenesis. Cancer Microenviron 3:149–166 [View Article][PubMed]
     [Google Scholar]
  25. Pera A., Campos C., Corona A., Sanchez-Correa B., Tarazona R., Larbi A., Solana R. 2014; CMV latent infection improves CD8+ T response to SEB due to expansion of polyfunctional CD57+ cells in young individuals. PLoS One 9:e88538 [View Article][PubMed]
     [Google Scholar]
  26. Salyakina D., Tsinoremas N. F. 2013; Viral expression associated with gastrointestinal adenocarcinomas in TCGA high-throughput sequencing data. Hum Genomics 7:23 [View Article][PubMed]
     [Google Scholar]
  27. Sanford E. J., Geder L., Laychock A., Rohner T. J., Rapp F. 1977; Evidence for the association of cytomegalovirus with carcinoma of the prostate. J Urol 118:789–792[PubMed]
     [Google Scholar]
  28. Sansoni P., Vescovini R., Fagnoni F. F., Akbar A., Arens R., Chiu Y. L., Cičin-Šain L., Dechanet-Merville J., Derhovanessian E. et al. 2014; New advances in CMV and immunosenescence. Exp Gerontol 55:54–62 [View Article][PubMed]
     [Google Scholar]
  29. Savva G. M., Pachnio A., Kaul B., Morgan K., Huppert F. A., Brayne C., Moss P. A. Medical Research Council Cognitive Function and Ageing Study 2013; Cytomegalovirus infection is associated with increased mortality in the older population. Aging Cell 12:381–387 [View Article][PubMed]
     [Google Scholar]
  30. Sobin L. H., Gospodarowicz M. K., Wittekind C. (editors) 2009 TNM Classification of Malignant Tumours, 7th edn. New York: Wiley-Blackwell;
     [Google Scholar]
  31. Söderberg-Nauclér C., Rahbar A., Stragliotto G. 2013; Survival in patients with glioblastoma receiving valganciclovir. N Engl J Med 369:985–986 [View Article][PubMed]
     [Google Scholar]
  32. Sole C. V., Calvo F. A., Ferrer C., Alvarez E., Carreras J. L., Ochoa E. 2015; Human cytomegalovirus and Epstein-Barr virus infection impact on 18F-FDG PET/CT SUVmax, CT volumetric and KRAS-based parameters of patients with locally advanced rectal cancer treated with neoadjuvant therapy. Eur J Nucl Med Mol Imaging 42:186–196 [View Article][PubMed]
     [Google Scholar]
  33. Stragliotto G., Rahbar A., Solberg N. W., Lilja A., Taher C., Orrego A., Bjurman B., Tammik C., Skarman P. et al. 2013; Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study. Int J Cancer 133:1204–1213 [View Article][PubMed]
     [Google Scholar]
  34. Tafvizi F., Fard Z. T. 2014; Detection of human cytomegalovirus in patients with colorectal cancer by nested-PCR. Asian Pac J Cancer Prev 15:1453–1457 [View Article][PubMed]
     [Google Scholar]
  35. Taher C., Frisk G., Fuentes S., Religa P., Costa H., Assinger A., Vetvik K. K., Bukholm I. R., Yaiw K. C. et al. 2014; High prevalence of human cytomegalovirus in brain metastases of patients with primary breast and colorectal cancers. Transl Oncol 7:732–740 [View Article][PubMed]
     [Google Scholar]
  36. Tsujii M., Kawano S., DuBois R. N. 1997; Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A 94:3336–3340 [View Article][PubMed]
     [Google Scholar]
  37. Tsutsui Y., Yamazaki Y. 1991; Subcellular distribution of the major immediate early proteins of human cytomegalovirus changes during infection. J Gen Virol 72:1415–1419 [View Article][PubMed]
     [Google Scholar]
  38. Wu T. C., Lee W. A., Pizzorno M. C., Au W. C., Chan Y. J., Hruban R. H., Hutchins G. M., Hayward G. S. 1992; Localization of the human cytomegalovirus 2.7-kb major early beta-gene transcripts by RNA in situ hybridization in permissive and nonpermissive infections. Am J Pathol 141:1247–1254[PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000558
Loading
Identification of human cytomegalovirus in tumour tissues of colorectal cancer and its association with the outcome of non-elderly patients
J. Gen. Virol. 97, 2411 (2016); https://doi.org/10.1099/jgv.0.000558
/content/journal/jgv/10.1099/jgv.0.000558
/content/journal/jgv/10.1099/jgv.0.000558
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error